Skip to main content

Closed

INSM: Insmed Incorporated Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+19.2% / yr

Operating margin-137.7%

ROIC-65.3%

Financially safe

Stretched

Debt / equity1.06×

Interest coverage-13.7×

Current ratio4.47×

Insmed Incorporated

INSMNASDAQ Global Select·USD·Closed

Insmed Incorporated

INSMNASDAQ·USD·Closed

$98.60

−2.85%

$98.60

−$2.89 (2.85%)

52W Range

7thpctl

Volume

0.74×avg

Mkt Cap

21.37BUSD

P/E

-17.1TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.74×avg

Market Cap

21.37BUSD

P/E Ratio

-17.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings